Acumen Pharmaceuticals, Inc. (ABOS)
0.2432
+0.02
(+8.81%)
USD |
NASDAQ |
Nov 09, 11:48
Acumen Pharmaceuticals Price to Book Value : 0.5083 for Nov. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 06, 2026 | 0.4671 |
| November 05, 2026 | 0.4468 |
| November 04, 2026 | 0.452 |
| November 03, 2026 | 0.4898 |
| November 02, 2026 | 0.5009 |
| October 30, 2026 | 0.4391 |
| October 29, 2026 | 4.786 |
| October 28, 2026 | 4.974 |
| October 27, 2026 | 4.723 |
| October 26, 2026 | 4.744 |
| October 23, 2026 | 4.138 |
| October 22, 2026 | 4.305 |
| October 21, 2026 | 4.242 |
| October 20, 2026 | 4.211 |
| October 19, 2026 | 3.699 |
| October 16, 2026 | 3.532 |
| October 15, 2026 | 3.490 |
| October 14, 2026 | 3.647 |
| October 13, 2026 | 3.793 |
| October 12, 2026 | 4.221 |
| October 09, 2026 | 4.472 |
| October 08, 2026 | 4.388 |
| October 07, 2026 | 4.388 |
| October 06, 2026 | 4.242 |
| October 05, 2026 | 4.451 |
| Date | Value |
|---|---|
| October 02, 2026 | 4.263 |
| October 01, 2026 | 4.326 |
| September 30, 2026 | 4.639 |
| September 29, 2026 | 2.835 |
| September 28, 2026 | 2.905 |
| September 25, 2026 | 2.829 |
| September 24, 2026 | 2.822 |
| September 23, 2026 | 2.911 |
| September 22, 2026 | 3.347 |
| September 21, 2026 | 3.271 |
| September 18, 2026 | 3.347 |
| September 17, 2026 | 3.246 |
| September 16, 2026 | 3.296 |
| September 15, 2026 | 3.650 |
| September 14, 2026 | 3.523 |
| September 11, 2026 | 3.688 |
| September 10, 2026 | 3.612 |
| September 09, 2026 | 3.599 |
| September 08, 2026 | 3.991 |
| September 04, 2026 | 4.016 |
| September 03, 2026 | 3.902 |
| September 02, 2026 | 3.915 |
| September 01, 2026 | 3.688 |
| August 31, 2026 | 3.599 |
| August 28, 2026 | 3.688 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.668 |
| Alnylam Pharmaceuticals, Inc. | 5.785 |
| Anika Therapeutics, Inc. | 1.430 |
| Savara, Inc. | 7.077 |
| Vericel Corp. | 7.624 |
Price to Book Value Related Metrics
| Price | 0.2432 |
| Earnings Yield | -635.9% |
| Market Cap | 17.59M |